Experience...Knowledge....Action...

Sunday, August 23, 2020

Compliance Policy for the Quantity of Bioavailability and Bioequivalence Samples


 Hi friends,

  Here shared a topic "Compliance Policy for the Quantity of Bioavailability and Bioequivalence Samples  Retained Under 21 CFR 320.38(c) Guidance for Industry by USFDA August 2020" .For details click on below link:

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/compliance-policy-quantity-bioavailability-and-bioequivalence-samples-retained-under-21-cfr-32038c


     Regards,

    htttps://www.bioanalyticalscience.com

No comments:

Post a Comment

If you have any doubts,please let me know